Acacia Pharma Group PLC (EUR)
ACPH
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range1.81 | 1.83
52-Wk Range1.20 | 4.00
Last Close1.81
Mkt Cap (m)99.35
Dividend yield-
ISINGB00BYWF9Y76
Volume23,863
Exchange VenueBRU

Company Profile

Acacia Pharma Group PLC is a pharmaceutical company, focused on the development and commercialization of hospital products for US and international markets to treat and prevent nausea and vomiting suffered by surgical and cancer patients.

Key Information
Price/Earning-
Price/Book6.91
Price/Sales-
P/CF-
Rev Growth (3 year avg)-
EPS Growth (3 year avg)-
Operating Margin % -
Net Margin %-
Return on Equity-2015.32
Debt/Equity0.38

Legal Documents

Prospectus
en 02/03/2018
Annual Report
en 31/12/2018

Financials

Income Statement
EUR201320142015201620172018
Revenue (m)------
Operating Income (m)---12-14-3-15
Net Income (m)---13-13-6-16
Basic EPS---4.85-5.08-0.12-0.35
Avg. Diluted Shares Outstanding (m)--335344
Balance Sheet
EUR201320142015201620172018
Current Assets (m)--810430
Non Current Assets (m)--
Total Assets (m)--810430
Current Liabilities (m)--1117214
Total Liabilities (m)------
Total Equity (m)---3-12-1819
Cash Flows
EUR201320142015201620172018
Operating Cash Flows (m)---10-10-4-12
Capital Expenditure (m)------
Figures are quoted in EUR unless stated otherwise
0.02 (0.99%)
1.83
Last Price